# DeFi Capital Markets, Inc.: financial statements, quarterly DCM · NYSE · CIK 102109 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/dcm.md) · [Financials](/companies/dcm/financials.md) · [Filings](/companies/dcm/filings.md) · [Insiders](/companies/dcm/insiders.md) Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/dcm/financials.md?period=annual). ## Income statement | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [3,717](/filings/0001410578-24-002023.md) | [4,655](/filings/0001410578-25-000141.md) | [4,446 d](/filings/0001410578-25-001522.md) | [4,599](/filings/0001410578-25-001850.md) | [7,203](/filings/0001104659-25-114128.md) | [5,535](/filings/0001104659-26-017568.md) | [6,227 d](/filings/0001104659-26-080359.md) | [3,824](/filings/0001104659-26-097233.md) | [760](/filings/0001104659-25-114128.md) | [22.5](/filings/0001104659-26-017568.md) | [240 d](/filings/0001104659-26-080359.md) | [110](/filings/0001104659-26-097233.md) | | Cost of revenue | $k | [2,409](/filings/0001410578-24-002023.md) | [3,153](/filings/0001410578-25-000141.md) | [3,367 d](/filings/0001410578-25-001522.md) | [3,511](/filings/0001410578-25-001850.md) | [5,205](/filings/0001104659-25-114128.md) | [4,513](/filings/0001104659-26-017568.md) | [3,503 d](/filings/0001104659-26-080359.md) | [3,130](/filings/0001104659-26-097233.md) | [301](/filings/0001104659-25-114128.md) | [300](/filings/0001104659-26-017568.md) | [313 d](/filings/0001104659-26-080359.md) | [100](/filings/0001104659-26-097233.md) | | Gross profit | $k | [1,308](/filings/0001410578-24-002023.md) | [1,502](/filings/0001410578-25-000141.md) | [1,080 d](/filings/0001410578-25-001522.md) | [1,088](/filings/0001410578-25-001850.md) | [1,998](/filings/0001104659-25-114128.md) | [1,022](/filings/0001104659-26-017568.md) | [2,724 d](/filings/0001104659-26-080359.md) | [694](/filings/0001104659-26-097233.md) | [459](/filings/0001104659-25-114128.md) | [(277)](/filings/0001104659-26-017568.md) | [(72.9) d](/filings/0001104659-26-080359.md) | [9.1](/filings/0001104659-26-097233.md) | | Research and development | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Selling, general and administrative | $k | [1,334](/filings/0001410578-24-002023.md) | [1,311](/filings/0001410578-25-000141.md) | [1,667 d](/filings/0001410578-25-001522.md) | [1,397](/filings/0001410578-25-001850.md) | [1,209](/filings/0001104659-25-114128.md) | [1,762](/filings/0001104659-26-017568.md) | [1,635 d](/filings/0001104659-26-080359.md) | [1,113](/filings/0001104659-26-097233.md) | [1,311](/filings/0001104659-25-114128.md) | [1,896](/filings/0001104659-26-017568.md) | [913 d](/filings/0001104659-26-080359.md) | [744](/filings/0001104659-26-097233.md) | | Operating income | $k | [(158)](/filings/0001410578-24-002023.md) | [114](/filings/0001410578-25-000141.md) | [(741) d](/filings/0001410578-25-001522.md) | [(397)](/filings/0001410578-25-001850.md) | [678](/filings/0001104659-25-114128.md) | [(871)](/filings/0001104659-26-017568.md) | [992 d](/filings/0001104659-26-080359.md) | [(531)](/filings/0001104659-26-097233.md) | [(929)](/filings/0001104659-25-114128.md) | [(2,187)](/filings/0001104659-26-017568.md) | [(1,007) d](/filings/0001104659-26-080359.md) | [(737)](/filings/0001104659-26-097233.md) | | Interest expense | $k | [33.5](/filings/0001410578-24-002023.md) | [36.3](/filings/0001410578-25-000141.md) | [35.4 d](/filings/0001410578-25-001522.md) | [44.9](/filings/0001410578-24-001526.md) | [89.6](/filings/0001410578-24-002023.md) | [77.4](/filings/0001410578-25-000141.md) | [50.4 d](/filings/0001104659-26-080359.md) | not reported | not reported | not reported | not reported | not reported | | Income tax | $k | [(4.7)](/filings/0001410578-24-002023.md) | not reported | not reported | not reported | [11.6](/filings/0001104659-25-114128.md) | [(11.6)](/filings/0001104659-26-017568.md) | not reported | not reported | [13.0](/filings/0001104659-25-114128.md) | [(114)](/filings/0001104659-26-017568.md) | [(16.0) d](/filings/0001104659-26-080359.md) | not reported | | Net income | $k | [(186)](/filings/0001410578-25-000141.md) | [102](/filings/0001410578-25-000141.md) | [(777) d](/filings/0001410578-25-001522.md) | [(442)](/filings/0001104659-26-017568.md) | [577](/filings/0001104659-26-017568.md) | [(937)](/filings/0001104659-26-017568.md) | [1,303 d](/filings/0001104659-26-080359.md) | [1,810](/filings/0001104659-26-097233.md) | [(1,000)](/filings/0001104659-26-017568.md) | [(2,287)](/filings/0001104659-26-017568.md) | [(1,009) d](/filings/0001104659-26-080359.md) | [(662)](/filings/0001104659-26-097233.md) | | Diluted EPS | $ per share | [(0.08)](/filings/0001410578-24-002023.md) | [0.04](/filings/0001410578-25-000141.md) | not reported | [(0.19)](/filings/0001410578-25-001850.md) | [0.25](/filings/0001104659-25-114128.md) | [(0.40)](/filings/0001104659-26-017568.md) | not reported | [0.78](/filings/0001104659-26-097233.md) | [(0.43)](/filings/0001104659-25-114128.md) | [(0.99)](/filings/0001104659-26-017568.md) | not reported | [(0.23)](/filings/0001104659-26-097233.md) | | Basic EPS | $ per share | [(0.08)](/filings/0001410578-24-002023.md) | [0.04](/filings/0001410578-25-000141.md) | not reported | [(0.19)](/filings/0001410578-25-001850.md) | [0.25](/filings/0001104659-25-114128.md) | [(0.40)](/filings/0001104659-26-017568.md) | not reported | [0.78](/filings/0001104659-26-097233.md) | [(0.43)](/filings/0001104659-25-114128.md) | [(0.99)](/filings/0001104659-26-017568.md) | not reported | [(0.23)](/filings/0001104659-26-097233.md) | - Revenue: us-gaap:Revenues, us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax - Cost of revenue: us-gaap:CostOfGoodsAndServicesSold - Gross profit: us-gaap:GrossProfit - Research and development: not reported - Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense - Operating income: us-gaap:OperatingIncomeLoss - Interest expense: us-gaap:InterestExpense - Income tax: us-gaap:IncomeTaxExpenseBenefit - Net income: us-gaap:NetIncomeLoss - Diluted EPS: us-gaap:EarningsPerShareDiluted - Basic EPS: us-gaap:EarningsPerShareBasic ## Balance sheet | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Cash and equivalents | $m | [0.3](/filings/0001410578-23-002550.md) | [0.0](/filings/0001410578-24-000064.md) | [0.1](/filings/0001410578-25-001522.md) | [0.3](/filings/0001410578-24-001526.md) | [0.2](/filings/0001410578-24-002023.md) | [0.1](/filings/0001410578-25-000141.md) | [0.3](/filings/0001104659-26-080359.md) | [0.5](/filings/0001410578-25-001850.md) | [5.2](/filings/0001104659-25-114128.md) | [4.3](/filings/0001104659-26-017568.md) | [3.5](/filings/0001104659-26-097233.md) | [3.7](/filings/0001104659-26-097233.md) | | Current assets | $m | [8.7](/filings/0001410578-23-002550.md) | [8.7](/filings/0001410578-24-000064.md) | [8.1](/filings/0001410578-25-001522.md) | [8.5](/filings/0001410578-24-001526.md) | [12.8](/filings/0001410578-24-002023.md) | [9.5](/filings/0001410578-25-000141.md) | [9.8](/filings/0001104659-26-080359.md) | [7.6](/filings/0001410578-25-001850.md) | [6.8](/filings/0001104659-25-114128.md) | [5.5](/filings/0001104659-26-017568.md) | [4.5](/filings/0001104659-26-097233.md) | [4.8](/filings/0001104659-26-097233.md) | | Total assets | $m | [9.0](/filings/0001410578-23-002550.md) | [8.9](/filings/0001410578-24-000064.md) | [8.3](/filings/0001410578-25-001522.md) | [8.7](/filings/0001410578-24-001526.md) | [12.9](/filings/0001410578-24-002023.md) | [9.6](/filings/0001410578-25-000141.md) | [9.8](/filings/0001104659-26-080359.md) | [7.6](/filings/0001410578-25-001850.md) | [6.8](/filings/0001104659-25-114128.md) | [5.5](/filings/0001104659-26-017568.md) | [4.5](/filings/0001104659-26-097233.md) | [4.9](/filings/0001104659-26-097233.md) | | Current liabilities | $m | [3.6](/filings/0001410578-23-002550.md) | [3.4](/filings/0001410578-24-000064.md) | [3.7](/filings/0001410578-25-001522.md) | [4.1](/filings/0001410578-24-001526.md) | [7.8](/filings/0001410578-24-002023.md) | [5.4](/filings/0001410578-25-000141.md) | [4.7](/filings/0001104659-26-080359.md) | [0.6](/filings/0001410578-25-001850.md) | [3.1](/filings/0001104659-25-114128.md) | [3.2](/filings/0001104659-26-017568.md) | [1.3](/filings/0001104659-26-097233.md) | [1.4](/filings/0001104659-26-097233.md) | | Total liabilities | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [1.3](/filings/0001104659-26-097233.md) | [1.4](/filings/0001104659-26-097233.md) | | Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Shareholders' equity | $m | [5.3](/filings/0001410578-25-000141.md) | [5.4](/filings/0001410578-25-000141.md) | [4.7](/filings/0001104659-26-080359.md) | [4.5](/filings/0001104659-26-017568.md) | [5.1](/filings/0001104659-26-017568.md) | [4.2](/filings/0001104659-26-017568.md) | [5.2](/filings/0001104659-26-097233.md) | [7.0](/filings/0001104659-26-097233.md) | [3.7](/filings/0001104659-26-017568.md) | [2.3](/filings/0001104659-26-017568.md) | [3.2](/filings/0001104659-26-097233.md) | [3.5](/filings/0001104659-26-097233.md) | - Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, us-gaap:Cash - Current assets: us-gaap:AssetsCurrent - Total assets: us-gaap:Assets - Current liabilities: us-gaap:LiabilitiesCurrent - Total liabilities: us-gaap:Liabilities - Long-term debt: not reported - Shareholders' equity: us-gaap:StockholdersEquity ## Cash flow | Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Operating cash flow | $k | [472 d](/filings/0001410578-24-002023.md) | [(425) d](/filings/0001410578-25-000141.md) | [378 d](/filings/0001410578-25-001522.md) | [(1,198)](/filings/0001410578-25-001850.md) | [(2,080) d](/filings/0001104659-25-114128.md) | [2,541 d](/filings/0001104659-26-017568.md) | [(312) d](/filings/0001104659-26-080359.md) | [1,070](/filings/0001104659-26-097233.md) | [2,871 d](/filings/0001104659-25-114128.md) | [(2,593) d](/filings/0001104659-26-017568.md) | [(811) d](/filings/0001104659-26-080359.md) | [(688)](/filings/0001104659-26-097233.md) | | Capital expenditure | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [45.4](/filings/0001104659-26-097233.md) | | Dividends paid | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [0.0 d](/filings/0001104659-26-017568.md) | [0.0 d](/filings/0001104659-26-080359.md) | not reported | | Share repurchases | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities - Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment - Dividends paid: us-gaap:PaymentsOfDividends - Share repurchases: not reported ## Shares | Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Diluted shares (weighted) | thousands of shares | [2,313](/filings/0001410578-23-002550.md) | [2,313](/filings/0001410578-24-000064.md) | [2,313](/filings/0001410578-24-001526.md) | [2,313](/filings/0001410578-24-002023.md) | [2,313](/filings/0001410578-25-000141.md) | [2,313](/filings/0001410578-25-001850.md) | [2,313](/filings/0001104659-25-114128.md) | [2,313](/filings/0001104659-26-017568.md) | [2,313](/filings/0001104659-26-097233.md) | [2,313](/filings/0001104659-25-114128.md) | [2,313](/filings/0001104659-26-017568.md) | [2,937](/filings/0001104659-26-097233.md) | - Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding Shares outstanding: 3,028,463 at 2026-08-14, from the cover of the [10-Q filed 2026-08-14](/filings/0001104659-26-097233.md) (dei:EntityCommonStockSharesOutstanding). Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:21 ET. No prices; not investment advice.